Healthcare Growth Equity/PE -- Quick Check
Hi everyone,
I am an entry level analyst at a good Reg + commercial due diligence firm based in a major city on east coast USA. Most of their clients are PE clients.
It is the type of company where one wants to become a subject matter expert on something specific within healthcare while also supporting investors on navigating CMS/HHS regulations + translating finc impact.
The issue is that it does not build up the type of deal execution/raw technicals that IB typically builds up; I feel as though this is what PE firms in HC space mainly care about, regardless of specialty.
Would a pivot to MBB/T2 consulting make more sense for an eventual PE exit? or an MBA?